Situation: A nurse works in a private fertility center that offers assisted reproductive technology (ART) and counsels couples about their options. After an embryo implants, which hormone keeps the corpus luteum producing progesterone until the placenta takes over?

The trophoblast of the implanted embryo secretes human chorionic gonadotropin (hCG), which keeps the corpus luteum producing progesterone until the placenta takes over at about 10 weeks. In a cycle without pregnancy, falling luteinizing hormone support lets the corpus luteum regress and menstruation follows.

Clinical context: ART and early pregnancy support

After fertilization and transfer, the implanted embryo must signal the maternal ovary that pregnancy has begun. The structure responsible for this signal is the trophoblast, the outer cell layer of the blastocyst that later forms the fetal portion of the placenta. Once implantation occurs, trophoblast cells secrete human chorionic gonadotropin (hCG).

hCG is structurally and functionally similar to luteinizing hormone (LH), and it binds the same LH receptor on the corpus luteum. This keeps the corpus luteum alive and actively secreting progesterone, which maintains the endometrial lining and prevents menstruation. In a non-pregnant cycle, LH support declines, the corpus luteum regresses, progesterone falls, and menses begins. In pregnancy, hCG substitutes for LH and rescues the corpus luteum from that fate.

Key point! The corpus luteum is not the permanent source of progesterone. Around 10 weeks of gestation, the placenta matures enough to produce progesterone on its own, and hCG levels naturally decline as the luteal-placental shift occurs.

Why the other options are incorrect

Hormone	Source	Role in early pregnancy	Why it is not the answer
Luteinizing hormone (LH)	Anterior pituitary	Triggers ovulation and supports corpus luteum in a non-pregnant cycle	LH levels fall after ovulation; the embryo does not produce LH
Human placental lactogen (hPL)	Placenta (syncytiotrophoblast)	Modulates maternal metabolism and insulin resistance; supports fetal nutrition	hPL rises later and does not maintain the corpus luteum
Follicle-stimulating hormone (FSH)	Anterior pituitary	Stimulates follicular growth in the ovary	FSH is suppressed during the luteal phase and is not the rescue signal
Human chorionic gonadotropin (hCG)	Trophoblast of implanted embryo	Binds LH receptors on corpus luteum to maintain progesterone secretion	Correct answer

Deeper look at the evidence

The classic view of hCG as simply a progesterone-driving signal has expanded. Research indicates that hCG also acts as a paracrine regulator during implantation, coordinating the molecular dialogue between the blastocyst and the uterine lining ^[1]. This means hCG has two complementary jobs in early pregnancy: it prepares the endometrium for implantation and, once implantation occurs, it sustains the corpus luteum.

The corpus luteum itself undergoes measurable growth during early pregnancy, and its volume correlates with the hormones it produces, including progesterone, estradiol, relaxin, and 17-hydroxyprogesterone ^[2]. This growth is driven by hCG stimulation. The timing of hCG exposure matters: studies that administered exogenous hCG to mimic implantation showed that the corpus luteum can be rescued only if hCG is given within a specific window after the LH surge ^[3]. If hCG arrives too late, the corpus luteum has already begun to regress and cannot be revived.

Watch out! In a normal menstrual cycle, the corpus luteum has a limited lifespan of about 14 days unless hCG appears. That is why a pregnancy test detecting hCG in urine or serum can be positive before a missed period—the embryo is already signaling the ovary to keep progesterone production going.

In ART settings, this physiology is directly relevant. When exogenous hCG is administered during early pregnancy, it can stimulate additional follicular activity and even secondary ovulation in some species, with measurable effects on serum progesterone ^[4]. While this specific study was conducted in mares, the principle reinforces that hCG is a potent luteotrophic signal capable of altering ovarian function during early gestation.

Clinical application for nursing care

For a couple undergoing ART, understanding hCG helps explain several clinical events. A positive serum hCG test confirms implantation has occurred. Serial hCG measurements that rise appropriately suggest the trophoblast is functioning and the corpus luteum is being supported. If progesterone supplementation is prescribed after embryo transfer, it is because the luteal phase may be inadequate until endogenous hCG from the implanted embryo reaches sufficient levels.

The luteal-placental shift at approximately 10 weeks means that progesterone support can often be tapered once the placenta assumes steroidogenesis. Before that point, the corpus luteum—kept alive by hCG—is the primary source of progesterone that maintains the pregnancy.